Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05026_nanopub.RAmGsg3QyG7chGOg2OiYFEMNIgkYyYtkNt0CwhnM8f_Go#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05026 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05026 label "APD125 [drugbank:DB05026]" assertion.
- drugbank:DB05026 seeAlso DB05026 assertion.
- drugbank:DB05026 description "APD125, an orally active compound, is developed for the treatment of insomnia. It is a highly selective antagonist at the 5-HT2A serotonin receptor. It increases non-REM sleep, the most restorative phase of the sleep cycle, without sacrificing REM or dream sleep. APD125 works through a mechanism of action that is different from currently marketed drugs." assertion.
- drugbank:DB05026 identifier "drugbank:DB05026" assertion.
- drugbank:DB05026 title "APD125" assertion.
- drugbank:DB05026 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05026 drugbank_vocabulary:drugbank-id "DB05026" assertion.
- drugbank:DB05026 bio2rdf_vocabulary:x-identifiers.org DB05026 assertion.
- drugbank:DB05026 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05026" assertion.
- drugbank:DB05026 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05026 bio2rdf_vocabulary:identifier "DB05026" assertion.